Neither insulin nor tablets is universally “better” for diabetes. The right choice depends on which type of diabetes you have, how much insulin your body still produces, and how well your blood sugar is currently controlled. For Type 1 diabetes, insulin is the only option. For Type 2 diabetes, most people start with tablets and may eventually need insulin, but many never do.
Type 1 Diabetes Requires Insulin
In Type 1 diabetes, the immune system destroys the cells in the pancreas that produce insulin. This leads to absolute insulin deficiency, meaning the body makes little to none on its own. No oral tablet can replace that missing insulin, so people with Type 1 need lifelong insulin injections or an insulin pump. There is no decision to make here: insulin is the treatment.
Type 2 Diabetes Usually Starts With Tablets
Type 2 diabetes is a different situation. Your pancreas still makes insulin, but your body doesn’t use it efficiently, and over time production can decline. Because there’s still some insulin in the system, oral medications can work by improving how your body responds to it, reducing the amount of sugar your liver releases, or helping your kidneys flush out excess glucose.
Metformin is the most commonly prescribed starting tablet. It’s inexpensive, well studied, and carries a low risk of causing dangerously low blood sugar. In a large retrospective study, metformin had the lowest rate of serious hypoglycemia among oral medications, at roughly 1.2 events per 100 patient-years. By comparison, some older oral drugs that stimulate insulin release (like glyburide) had rates nearly six times higher.
For most people with newly diagnosed Type 2 diabetes and moderately elevated blood sugar, tablets alone can bring levels into a healthy range. The goal is typically to get your HbA1c (a measure of average blood sugar over three months) below 7%.
When Tablets Are No Longer Enough
Type 2 diabetes is progressive. The insulin-producing cells in your pancreas gradually lose function over years, and a treatment plan that worked well initially may stop keeping your blood sugar in range. When oral medications can no longer hit your HbA1c target, insulin becomes necessary.
There are also specific situations where insulin is the clear choice for Type 2 diabetes, even early on:
- Very high blood sugar at diagnosis. When glucose levels are extremely elevated (sometimes called glucose toxicity), insulin can bring them down quickly. A few weeks of “rescue” insulin therapy can restore some function, and some people transition back to tablets afterward.
- Pregnancy. Many oral diabetes drugs aren’t safe during pregnancy, making insulin the standard treatment.
- Acute illness or surgery. Blood sugar can spike unpredictably during serious illness or after operations, and insulin offers precise, flexible dosing.
- Contraindications to oral drugs. Kidney or liver problems can rule out certain tablets, leaving insulin as the safer option.
Newer Tablets Have Changed the Equation
The tablet-versus-insulin conversation looks very different today than it did ten years ago, thanks to two newer classes of oral medication.
SGLT2 inhibitors work by helping your kidneys remove excess sugar through urine. Beyond blood sugar control, they offer something insulin doesn’t: significant heart and kidney protection. Clinical trials have shown that SGLT2 inhibitors reduce the risk of heart failure hospitalization, cardiovascular death, and progression to end-stage kidney disease. These benefits hold even in people who don’t have diabetes, which tells you the protective effects go beyond glucose lowering.
Oral GLP-1 receptor agonists (the tablet form of semaglutide, for example) represent another shift. In clinical trials, patients already on insulin who added oral semaglutide at its highest dose saw their HbA1c drop by an additional 1.2 percentage points compared to placebo. By one year, those patients also needed an average of 17 fewer units of insulin per day. In other words, these newer tablets can reduce or sometimes eliminate the need for insulin injections in people who were already using them.
Weight Gain: A Key Difference
Insulin is effective at lowering blood sugar, but it commonly causes weight gain. This can be frustrating because excess weight makes Type 2 diabetes harder to manage, creating a cycle where you need more insulin as you gain weight.
Metformin, by contrast, is weight-neutral or causes modest weight loss. A meta-analysis of 38 randomized trials found that patients on metformin gained about 2.4 kilograms (roughly 5 pounds) less than those on insulin. Newer oral options like SGLT2 inhibitors and GLP-1 tablets also promote weight loss, which is one reason they’ve become so popular in Type 2 diabetes management.
Hypoglycemia Risk
Low blood sugar (hypoglycemia) is the most common serious side effect of diabetes treatment, and it’s more dangerous than many people realize. Severe episodes can cause confusion, seizures, or loss of consciousness.
Insulin carries the highest risk of hypoglycemia because it lowers blood sugar regardless of what you’ve eaten or how active you’ve been. You have to carefully balance your dose with meals and exercise. Metformin and SGLT2 inhibitors rarely cause hypoglycemia on their own because they work through mechanisms that don’t force blood sugar below normal levels. Older tablet classes that directly stimulate insulin release from the pancreas (sulfonylureas like glipizide or glyburide) do carry meaningful hypoglycemia risk, though still generally less than injected insulin.
Sticking With Treatment Long Term
The best medication only works if you actually take it, and adherence data consistently favors pills over injections. A study comparing oral and injectable forms of the same drug class found that 65% of patients on the oral version were still taking it consistently after one year, compared to just 39% on the injectable version. Fear of needles, the inconvenience of injections, and the social stigma of injecting in public all contribute to lower adherence with insulin.
That said, modern insulin delivery has improved. Insulin pens are more discreet and less painful than older syringes, and continuous glucose monitors can help prevent the dangerous lows that make people reluctant to use insulin. For those who do need insulin, these tools make the experience far more manageable than it used to be.
How Treatment Typically Progresses
For most people with Type 2 diabetes, treatment follows a general path. You start with lifestyle changes and metformin. If your blood sugar isn’t controlled after a few months, a second oral medication gets added, often an SGLT2 inhibitor or a GLP-1 based drug, especially if you have heart disease, kidney disease, or need to lose weight. If two or three oral medications still aren’t enough, basal insulin (a long-acting injection taken once daily) gets layered in. Some people eventually need mealtime insulin as well.
This isn’t a failure. It’s the natural progression of the disease. The goal at every stage is the same: keep blood sugar in a range that prevents complications like nerve damage, kidney disease, and vision loss. Sometimes that requires tablets, sometimes insulin, and often a combination of both. Adding metformin to insulin, for instance, lowers HbA1c by an additional 0.6 percentage points on average compared to insulin alone, while helping limit weight gain.
The practical answer for most people with Type 2 diabetes is that tablets are the better starting point because they’re easier to use, carry less hypoglycemia risk, can protect the heart and kidneys, and don’t cause weight gain. But insulin remains an essential tool when the disease progresses or when blood sugar needs to come down quickly. They’re not competitors so much as teammates in a long-term treatment plan.